Glycyrrhizic acid monopotassium salt tablets
Function and Efficacy
1. Liver protection and anti-hepatitis effect: Monopotassium glycyrrhizinate can significantly reduce the degeneration and necrosis of liver cells, reduce the inflammatory response of liver cell interstitium, inhibit the proliferation of liver cell fibers, thereby reducing the incidence of liver cirrhosis, and promoting the regeneration of liver cells. 2. Anti-inflammatory and anti-allergic effect: Monopotassium glycyrrhizinate can inhibit the activation of the fibrinolytic enzyme system, prevent the promotion of capillary permeability by serum, inhibit the hyperpermeability of wax, and inhibit the formation of granulomas, and also have an inhibitory effect on delayed allergic reactions. 3. Detoxification effect: Monopotassium glycyrrhizinate is decomposed into glycyrrhetinic acid and glucuronic acid in the liver, which can combine with toxic substances to play a detoxification effect. 4. Protective cell effect. Principle: Rabbits were gavaged with 15 mg/kg of monopotassium glycyrrhizinate for 6 consecutive weeks. The results showed that the weight of the adrenal glands was slightly reduced, and no significant effects were found on other organs.
Ingredients
Glycyrrhizic acid monopotassium salt.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Monopotassium glycyrrhizateIngredients |
1. Liver protection and anti-hepatitis effect: It can significantly reduce liver cell degeneration and necrosis, reduce liver cell interstitial inflammatory response, inhibit liver cell fibrosis, reduce the incidence of liver cirrhosis, promote liver cell regeneration, etc. 2. Anti-inflammatory and anti-allergic effect: It can inhibit the activation of the fibrinolytic enzyme system, prevent serum from promoting capillary permeability, inhibit the hyperpermeability of wax, inhibit the formation of granulomas, and also have an inhibitory effect on delayed allergic reactions. 3. Degradation effect: It is decomposed into glycyrrhetinic acid and glucuronic acid in the liver, which can combine with toxic substances to play a detoxification role. 4. Cell protection effect. More |
42294-03-1 | 2 |
Appearance
This product is a sugar-coated tablet. After removing the sugar coating, it appears light brown and tastes sweet.
Indication
Hepatitis treatment drug, used for chronic hepatitis B.
Usage and Dosage
Oral administration: 1 tablet (150 mg) at a time, 2 times a day (300 mg).
Adverse Reactions
A small number of patients experience dizziness, nausea, chest tightness, dry mouth, fatigue, rash and low fever during use. Mild symptoms can be relieved or disappear in a short period of time without treatment; severe symptoms require immediate medical attention. Some patients may experience hypokalemia and high blood pressure. Very few patients experience mild facial or lower limb edema after long-term use, and very few patients experience hyperplasia of body hair.
Precautions
It is contraindicated for those with allergic constitution or allergic to the ingredients of this product.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed. Validity period: 2 years.
Packaging Specification
75mg
Validity Period
24 months
Manufacturer
Shandong Shanda Kangnuo Pharmaceutical Co., Ltd.
-
Founded in:
2002-09-30 -
Address:
In Shandong University Science and Technology Park, Yingxiu Road, Jinan High-tech Development Zone -
Tax NO.:
91370100743380534M -
Registered Funds:
13 million yuan -
Email: